Insider Stock Trading History of Zarrabian Saiid


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Zarrabian Saiid since year 2005. The trader's CIK number is 1495521. At the time of this reporting, Zarrabian Saiid is the Interim CEO of Delmar Pharmaceuticals, Inc. . (stock ticker symbol DMPI). See this page for all insider trading activities at Delmar Pharmaceuticals, Inc. .

Note that in the past Zarrabian Saiid also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Zarrabian Saiid since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-11-14 DMPI Delmar Pharmaceuticals, Inc. Buy 60,900 .83 50,547
2015-05-14 LJPC La Jolla Pharmaceutical Co Buy 307 19.50 5,986
2014-07-31 LJPC La Jolla Pharmaceutical Co Buy 381 9.53 3,630

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Zarrabian Saiid (Interim CEO of Delmar Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.